Skip to main content Skip to navigation
Safer gene therapy delivery reduces cancer risk
November 7, 2016

By Eric Sorensen, WSU science writer

Trobridge-80SPOKANE, Wash. – A Washington State University researcher has developed a way to reduce the development of cancer cells that are an infrequent but dangerous byproduct of gene therapy.

Licensing deal will help Genus combat deadly cattle disease
July 27, 2016

srikumaran-s-2010-80PULLMAN, Wash. – A gene editing technology developed at Washington State University is being licensed to Genus plc, a global animal genetics company, to develop cattle that are more resistant to bovine respiratory disease (BRD).

Scientist develops gene therapy for muscle wasting
July 26, 2016

By Seth Truscott, College of Agricultural, Human & Natural Resource Sciences

Dan-RodgersPULLMAN, Wash. – A discovery by Washington State University scientist Dan Rodgers and collaborator Paul Gregorevic could save millions of people suffering from muscle wasting disease.

Researcher finds potential new use for old drugs
November 12, 2013

By Lorraine Nelson, College of Pharmacy

Poon-G-2013-80

PULLMAN, Wash. – A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found.

Researcher studies prostate cancer gene mutations
July 24, 2013

TrobridgePULLMAN, Wash. – The genes involved in the progression of prostate cancer from non-threatening to highly malignant are the focus of a new research project at Washington State University.

Grant D. Trobridge has received an award of $417,818 from the National Cancer Institute to identify which gene mutations cause the cancer to become threatening.

Prostate cancer is generally accepted as slow growing. It sometimes remains confined to the prostate gland and needs little or no treatment, while other times it spreads quickly.

“We know that several key genes have to be mutated before you get cancer,” Trobridge said. “Different tumors … » More …